The Why
Being overweight affects conditions such as asthma, sleep apnea, diabetes, cardiovascular disease, osteoarthritis, back pain, and obesity hypoventilation syndrome. Adding new drug therapies to treatment protocols is showing promising results for millions of people.
Results
We’ve conducted clinical trials for new drug therapies that are helping patients achieve impactful weight loss.
- Semaglutide approved for weight loss by the FDA December 2017